New Note Offerings Available Now!

Are 15% Returns
Too Good to Be True?
What You Need
to Know About
Supervest MCAs

August 28, 2025

Start Investing

Let’s face it—15% returns sound incredible. So what’s the catch?

Here’s the truth: Not all 15% opportunities are built the same. But at Supervest, the risk is matched with structure, vetting, and transparency.

Through our platform, accredited investors access Merchant Cash Advance (MCA) portfolios designed to deliver strong passive income with short terms, high yield, and real underlying business activity.

🛡 How Supervest Protects Your Capital

Here’s what makes Supervest different from “too good to be true” schemes:

✔️ vetted MCA portfolios by experienced underwriting teams

✔️ Diversified note portfolio exposure to minimize single-merchant risk

✔️ Monthly or quarterly payouts from promissory notes

✔️ Transparent documentation on repayment structures and fees

These are not crypto projects or real estate flips. These are contracted cash flows backed by active businesses operating in sectors like retail, healthcare, logistics, and more.

🔍 Due Diligence Without the Overhead

With Supervest, you:

  • Control your investment selections
  • Review terms, structure, and history
  • Get consistent reporting and tracking through your dashboard

We simplify what used to require an investment committee or fund manager—and put the power in your hands.

🚨 So… Is It “Too Good to Be True”?

Not when:

  • The opportunity is structured, collateralized, and verified
  • The business model has a proven repayment track record
  • You’re using a platform like Supervest that does the vetting for you

15% returns are real—when you know where to look. With Supervest MCAs, they’re within reach.

🔐 Invest Smarter. Earn Stronger.

Accredited investors are using Supervest to escape the limits of bonds and build high-yield, passive portfolios powered by merchant receivables.

You can too.

👉 Explore MCA Deals Now

All investments carry risk. Supervest offerings are available exclusively to accredited investors. Please review all offering documentation and consult with a licensed advisor where appropriate.

 

Back to Insights